Chemistry Wealth Management’s HCA Healthcare HCA Stock Holding History

Chemistry Wealth Management’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$278K	Buy	+714	New	+$302K	0.04%	180

Other funds holding HCA

Metropolis Capital Amersham, United Kingdom $3.45B AUM 1.26% 1-Year Est. Return

LDB

Lee, Danner & Bass Nashville, Tennessee $1.73B AUM 36.69% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

MIHAS

Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Milford Funds Auckland $6.14B AUM

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ACM

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Chemistry Wealth Management's HCA Position: Q2 2026 in Review

Chemistry Wealth Management opened a new position in HCA Healthcare (HCA) in Q2 2026: 714 shares worth $278K. The stake represents 0.04% of the portfolio and ranks #180 among its holdings.

549 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

Chemistry Wealth Management held 714 shares of HCA Healthcare worth $278K as of Q2 2026.
HCA Healthcare was a new Chemistry Wealth Management position in Q2 2026.
HCA Healthcare made up 0.04% of Chemistry Wealth Management's portfolio in Q2 2026, its #180 holding.
549 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Chemistry Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.